• Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Kabradg Share Price

    Kabra Drugs Share PriceKabra Drugs

    Small Cap 1.8k Result
    ₹4.26
    0.2 (4.93%)
    As on 30 September, 2023 | 05:25 BSE: 524322 NSE: KABRADGISIN: INE323K01017

    Kabra Drugs Performance

    Day Range

    • Low
    • High
    4.26

    52 Week Range

    • Low
    • High
    4.26
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Kabra Drugs

    Start SIP

    Kabra Drugs Share Price

    • Over 1 Month 13.3%
    • Over 3 Month -21.11%
    • Over 6 Month -23.52%
    • Over 1 Year -17.44%

    Kabra Drugs Key Statistics

    Kabra Drugs Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 000000
    Operating Expenses Qtr Cr 000000
    Operating Profit Qtr Cr 000000
    Depreciation Qtr Cr 000000
    Interest Qtr Cr 000000
    Tax Qtr Cr 000000
    Net Profit Qtr Cr 000000
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 00
    Operating Expenses Annual Cr 00
    Operating Profit Annual in Cr 00
    Depreciation Cr 00
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr 00
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 0
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr 0
    Net Cash Flow Annual Cr 0
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr -10
    Fixed Assets Annual Cr 00
    Total Non Current Assets Annual Cr 00
    Total Current Assets Annual Cr 11
    Total Assets Annual Cr 11
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs -2-1
    ROE Annual % 00
    ROCE Annual % -5247
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 00
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %

    Kabra Drugs Technicals

    EMA & SMA

    Current Price
    ₹4.26
    0.2 (4.93%)
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹3.9
    • 50 Day
    • ₹4.25
    • 100 Day
    • ₹4.36
    • 200 Day
    • ₹4.19
    • 20 Day
    • ₹3.71
    • 50 Day
    • ₹4.55
    • 100 Day
    • ₹4.41
    • 200 Day
    • ₹4.42

    Kabra Drugs Resistance and Support

    PIVOT
    ₹4.26
    Resistance
    First Resistance ₹4.26
    Second Resistance ₹4.26
    Third Resistance ₹4.26
    RSI 56.33
    MFI 51.48
    MACD Single Line -0.33
    MACD -0.21
    Support
    First Resistance ₹4.26
    Second Resistance ₹4.26
    Third Resistance ₹4.26

    Kabra Drugs Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 100 10,000 100
    Week 967 96,725 100
    1 Month 895 89,456 100
    6 Month 224 22,420 99.94

    Kabra Drugs Result Highlights

    Kabra Drugs Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Kabra Drugs Corporate Action

    Date Purpose Remarks
    2023-08-14 Quarterly Results
    2023-05-30 Audited Results
    2023-02-14 Quarterly Results
    2022-11-14 Quarterly Results
    2022-08-13 Quarterly Results
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Kabra Drugs FAQs

    What is Share Price of Kabra Drugs ?

    Kabra Drugs share price is ₹4 As on 30 September, 2023 | 05:11

    What is the Market Cap of Kabra Drugs ?

    The Market Cap of Kabra Drugs is ₹1.9 Cr As on 30 September, 2023 | 05:11

    What is the P/E ratio of Kabra Drugs ?

    The P/E ratio of Kabra Drugs is -4.8 As on 30 September, 2023 | 05:11

    What is the PB ratio of Kabra Drugs ?

    The PB ratio of Kabra Drugs is -2.6 As on 30 September, 2023 | 05:11

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.